Published in J Electrocardiol on August 21, 2006
The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat (2009) 2.54
Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol (2008) 2.42
[Prenatal diagnosis of Down syndrome in Denmark 1980-1998 and future progress perspectives]. Ugeskr Laeger (2002) 1.97
Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet (2012) 1.89
Using preventive home monitoring to reduce hospital admission rates and reduce costs: a case study of telehealth among chronic obstructive pulmonary disease patients. J Telemed Telecare (2012) 1.83
Autonomic alterations and cardiac changes in epilepsy. Epilepsia (2010) 1.83
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J (2008) 1.76
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail (2010) 1.69
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest (2008) 1.69
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J (2006) 1.63
Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res (2003) 1.61
Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. Drug Saf (2009) 1.58
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J (2005) 1.58
Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT. J Cardiovasc Electrophysiol (2013) 1.52
Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation (2008) 1.51
Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation (2012) 1.49
T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. Heart Rhythm (2004) 1.46
Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A. Circ J (2014) 1.45
The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote. Circ Cardiovasc Genet (2013) 1.44
The genetic basis of Brugada syndrome: a mutation update. Hum Mutat (2009) 1.44
Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. Clin Chem (2002) 1.40
Long pacing pulses reduce phrenic nerve stimulation in left ventricular pacing. J Cardiovasc Electrophysiol (2014) 1.40
The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R). Heart Rhythm (2013) 1.40
Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs (2011) 1.39
Mutations in sodium channel β-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res (2010) 1.38
Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm (2008) 1.27
Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat (2009) 1.26
Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol (2005) 1.26
One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Eur J Hum Genet (2005) 1.25
The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol (2009) 1.21
Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet (2009) 1.21
Interrater reliability of diagnostic methods in traditional Indian ayurvedic medicine. Evid Based Complement Alternat Med (2013) 1.17
Reliability studies of diagnostic methods in Indian traditional Ayurveda medicine: An overview. J Ayurveda Integr Med (2013) 1.17
High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet (2012) 1.17
Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency. Eur J Hum Genet (2004) 1.16
The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet (2009) 1.15
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol (2009) 1.10
Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome. Heart Rhythm (2005) 1.08
J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study. J Am Coll Cardiol (2013) 1.08
Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. Am J Cardiol (2005) 1.06
Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet (2012) 1.06
The automatic lung parameter estimator (ALPE) system: non-invasive estimation of pulmonary gas exchange parameters in 10-15 minutes. J Clin Monit Comput (2002) 1.06
ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn (2003) 1.04
Risk of atrial fibrillation as a function of the electrocardiographic PR interval: results from the Copenhagen ECG Study. Heart Rhythm (2013) 1.03
Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol (2010) 1.03
Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem (2002) 1.03
Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol (2006) 1.02
Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery. Anesthesiology (2004) 1.01
Non-invasive estimation of shunt and ventilation-perfusion mismatch. Intensive Care Med (2003) 1.01
Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol (2011) 0.99
The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Neurobiol Aging (2008) 0.99
Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol (2003) 0.97
C-reactive protein is associated with heart rate variability. Ann Noninvasive Electrocardiol (2007) 0.96
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation (2004) 0.96
Patients' use of self-monitored readings for managing everyday life with COPD: a qualitative study. Telemed J E Health (2013) 0.96
Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int J Cancer (2009) 0.95
Long QT syndrome in South Africa: the results of comprehensive genetic screening. Cardiovasc J Afr (2013) 0.94
Automated time-resolved immunofluorometric assay for Toxoplasma gondii-specific IgM and IgA antibodies: study of more than 130,000 filter-paper blood-spot samples from newborns. Clin Chem (2002) 0.94
Reference values of electrocardiogram repolarization variables in a healthy population. J Electrocardiol (2009) 0.94
Fc γ receptor IIIB (FcγRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children. PLoS One (2012) 0.94
Flow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition. Malar J (2012) 0.94
Cost-utility analysis of a telerehabilitation program: a case study of COPD patients. Telemed J E Health (2012) 0.93
Therapeutic hypothermia and ventricular fibrillation storm in early repolarization syndrome. Heart Rhythm (2010) 0.93
Closed-loop control of the heart rate by electrical stimulation of the vagus nerve. Med Biol Eng Comput (2006) 0.92
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate. Vaccine (2011) 0.91
New descriptors of T-wave morphology are independent of heart rate. J Electrocardiol (2008) 0.91
Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study. Clin Drug Investig (2012) 0.90
Capillary electrophoresis-based single strand DNA conformation analysis in high-throughput mutation screening. Hum Mutat (2003) 0.90
Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention. Am J Cardiol (2012) 0.90
Focality assessment in transcranial magnetic stimulation with double and cone coils. J Clin Neurophysiol (2006) 0.90
First trimester maternal serum pregnancy-specific beta-1-glycoprotein (SP1) as a marker of adverse pregnancy outcome. Prenat Diagn (2009) 0.89
The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure. Immunobiology (2011) 0.89
The prevalence of chromosome 22q11.2 deletions in 2,478 children with cardiovascular malformations. A population-based study. Am J Med Genet A (2011) 0.88
Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients. Biochem Biophys Res Commun (2007) 0.88
ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn (2006) 0.88
Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides. Biochem Biophys Res Commun (2010) 0.88
First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenat Diagn (2008) 0.88
Under surveillance, yet looked after: telehomecare as viewed by patients and their spouse/partners. Eur J Cardiovasc Nurs (2008) 0.88
Detecting 22q11.2 deletions by use of multiplex ligation-dependent probe amplification on DNA from neonatal dried blood spot samples. J Mol Diagn (2010) 0.88